Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,treasuryStock,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,currency,priceHint,shortName,exchange,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,exchangeDataDelayedBy,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,epsTrailingTwelveMonths,marketState,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,market,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,ELLXF,34734000.0,315063008,,,-7324500,,-7102000,5807000,1861500,-4547000,-4547000,-24500,-24500,,,,-221000,3580000,8127000,1718500,-2777500,,-7103500,-7102000,917000.0,6819000.0,35651000.0,967000.0,42470000.0,217730000.0,283000.0,-191050000.0,92000.0,8971000.0,27743000.0,4995000.0,8971000.0,3883000.0,35354000.0,2316000.0,1700000.0,250000.0,4735000.0,1818000.0,1902000,-63000,-340500,9256500,593000,10244500,5487000,-2000,-3704500,557500,-1077500,354500,-647500,1195500,-98500,30359000.0,en-US,US,EQUITY,False,Delayed Quote,0.0776,1630507486,-0.004900001,0.0776,0.0776,0.0776,434,-0.04515028,-0.3678222,24448890,0.6807018,15,America/New_York,EDT,-14400000,False,False,USD,4,ELIXINOL WELLNESS LTD,PNK,0.114,0.086194724,-0.008594722,-0.09971285,0.12275028,0,finmb_545070079,Other OTC,Elixinol Wellness Limited,AUD,63740,19813,0.006400004,0.0898877,0.0712 - 0.245,-0.1674,-0.6832653,0.0712,0.245,-0.439,REGULAR,-5.939395,0.0776 - 0.0776,0.0825,0.0,0.0,0,0,us_market,0.93,,,0.245,0.0712,0.0862,0.1228,63.74k,19.81k,315.06M,,234.97M,14.85%,10.12%,,,,,,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",0.00%,-168.73%,-19.36%,-142.12%,15.01M,0.08,,6.67M,-23.58M,-104.51M,-0.4390,,27.74M,0.09,2.65M,7.44,7.08,0.11,-22.62M,9.26M,Value,2000,Healthcare,"Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. It distributes hemp-derived cannabidiol products under the Elixinol brand. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.",Sydney,61 2 4044 4585,NSW,1609372800,Australia,http://www.elixinolglobal.com,86400,680 George Street,61 2 4044 4585,Drug Manufacturers—Specialty & Generic,Level 12
t-1,ELLXF,34734000.0,315063008,,,-7324500,,-7102000,5807000,1861500,-4547000,-4547000,-24500,-24500,,,,-221000,3580000,8127000,1718500,-2777500,,-7103500,-7102000,917000.0,6819000.0,35651000.0,967000.0,42470000.0,217730000.0,283000.0,-191050000.0,92000.0,8971000.0,27743000.0,4995000.0,8971000.0,3883000.0,35354000.0,2316000.0,1700000.0,250000.0,4735000.0,1818000.0,1902000,-63000,-340500,9256500,593000,10244500,5487000,-2000,-3704500,557500,-1077500,354500,-647500,1195500,-98500,30359000.0,en-US,US,EQUITY,False,Delayed Quote,0.0776,1630507486,-0.004900001,0.0776,0.0776,0.0776,434,-0.04515028,-0.3678222,24448890,0.6807018,15,America/New_York,EDT,-14400000,False,False,USD,4,ELIXINOL WELLNESS LTD,PNK,0.114,0.086194724,-0.008594722,-0.09971285,0.12275028,0,finmb_545070079,Other OTC,Elixinol Wellness Limited,AUD,63740,19813,0.006400004,0.0898877,0.0712 - 0.245,-0.1674,-0.6832653,0.0712,0.245,-0.439,REGULAR,-5.939395,0.0776 - 0.0776,0.0825,0.0,0.0,0,0,us_market,0.93,,,0.245,0.0712,0.0862,0.1228,63.74k,19.81k,315.06M,,234.97M,14.85%,10.12%,,,,,,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",0.00%,-168.73%,-19.36%,-142.12%,15.01M,0.08,,6.67M,-23.58M,-104.51M,-0.4390,,27.74M,0.09,2.65M,7.44,7.08,0.11,-22.62M,9.26M,Value,2000,Healthcare,"Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. It distributes hemp-derived cannabidiol products under the Elixinol brand. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.",Sydney,61 2 4044 4585,NSW,1609372800,Australia,http://www.elixinolglobal.com,86400,680 George Street,61 2 4044 4585,Drug Manufacturers—Specialty & Generic,Level 12
t-2,ELLXF,31048000.0,315063008,,,-42814500,,-45151000,8583000,1471500,-8116500,-8116500,24500,-24500,,,,2321000,3925000,12041500,2453500,-34698000,,-45135500,-45151000,1137000.0,8794000.0,32185000.0,1605000.0,40979000.0,198566000.0,2064000.0,-176846000.0,,10465000.0,16769000.0,6412000.0,10465000.0,7570000.0,28978000.0,3294000.0,1254000.0,250000.0,8891000.0,3377000.0,0,1340000,-366500,4516000,593000,5494500,-1802000,-52000,-7606000,906000,-1077500,354500,-612000,36564500,-49000,22566000.0,en-US,US,EQUITY,False,Delayed Quote,0.0776,1630507486,-0.004900001,0.0776,0.0776,0.0776,434,-0.04515028,-0.3678222,24448890,0.6807018,15,America/New_York,EDT,-14400000,False,False,USD,4,ELIXINOL WELLNESS LTD,PNK,0.114,0.086194724,-0.008594722,-0.09971285,0.12275028,0,finmb_545070079,Other OTC,Elixinol Wellness Limited,AUD,63740,19813,0.006400004,0.0898877,0.0712 - 0.245,-0.1674,-0.6832653,0.0712,0.245,-0.439,REGULAR,-5.939395,0.0776 - 0.0776,0.0825,0.0,0.0,0,0,us_market,0.93,,,0.245,0.0712,0.0862,0.1228,63.74k,19.81k,315.06M,,234.97M,14.85%,10.12%,,,,,,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",0.00%,-168.73%,-19.36%,-142.12%,15.01M,0.08,,6.67M,-23.58M,-104.51M,-0.4390,,27.74M,0.09,2.65M,7.44,7.08,0.11,-22.62M,9.26M,Value,2000,Healthcare,"Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. It distributes hemp-derived cannabidiol products under the Elixinol brand. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.",Sydney,61 2 4044 4585,NSW,1609372800,Australia,http://www.elixinolglobal.com,86400,680 George Street,61 2 4044 4585,Drug Manufacturers—Specialty & Generic,Level 12
t-3,ELLXF,31048000.0,315063008,,,-42814500,,-45151000,8583000,1471500,-8116500,-8116500,24500,-24500,,,,2321000,3925000,12041500,2453500,-34698000,,-45135500,-45151000,1137000.0,8794000.0,32185000.0,1605000.0,40979000.0,198566000.0,2064000.0,-176846000.0,,10465000.0,16769000.0,6412000.0,10465000.0,7570000.0,28978000.0,3294000.0,1254000.0,250000.0,8891000.0,3377000.0,0,1340000,-366500,4516000,593000,5494500,-1802000,-52000,-7606000,906000,-1077500,354500,-612000,36564500,-49000,22566000.0,en-US,US,EQUITY,False,Delayed Quote,0.0776,1630507486,-0.004900001,0.0776,0.0776,0.0776,434,-0.04515028,-0.3678222,24448890,0.6807018,15,America/New_York,EDT,-14400000,False,False,USD,4,ELIXINOL WELLNESS LTD,PNK,0.114,0.086194724,-0.008594722,-0.09971285,0.12275028,0,finmb_545070079,Other OTC,Elixinol Wellness Limited,AUD,63740,19813,0.006400004,0.0898877,0.0712 - 0.245,-0.1674,-0.6832653,0.0712,0.245,-0.439,REGULAR,-5.939395,0.0776 - 0.0776,0.0825,0.0,0.0,0,0,us_market,0.93,,,0.245,0.0712,0.0862,0.1228,63.74k,19.81k,315.06M,,234.97M,14.85%,10.12%,,,,,,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",0.00%,-168.73%,-19.36%,-142.12%,15.01M,0.08,,6.67M,-23.58M,-104.51M,-0.4390,,27.74M,0.09,2.65M,7.44,7.08,0.11,-22.62M,9.26M,Value,2000,Healthcare,"Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. It distributes hemp-derived cannabidiol products under the Elixinol brand. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.",Sydney,61 2 4044 4585,NSW,1609372800,Australia,http://www.elixinolglobal.com,86400,680 George Street,61 2 4044 4585,Drug Manufacturers—Specialty & Generic,Level 12
